Hide metadata

dc.date.accessioned2018-03-15T13:43:46Z
dc.date.available2018-03-15T13:43:46Z
dc.date.created2017-07-06T10:20:02Z
dc.date.issued2017
dc.identifier.citationIrgens, Audun Campbell Hoffart, Asle Nysæter, Tor Erik Haaland, Vegard Øksendal Borge, Finn Magnus Pripp, Are Hugo Martinsen, Egil Wilhelm Dammen, Toril . Thought field therapy compared to cognitive behavioral therapy and wait-list for agoraphobia: A randomized, controlled study with a 12-month follow-up. Frontiers in Psychology. 2017, 8
dc.identifier.urihttp://hdl.handle.net/10852/61016
dc.description.abstractBackground: Thought field therapy (TFT) is used for many psychiatric conditions, but its efficacy has not been sufficiently documented. Hence, there is a need for studies comparing TFT to well-established treatments. This study compares the efficacy of TFT and cognitive behavioral therapy (CBT) for patients with agoraphobia. Methods: Seventy-two patients were randomized to CBT (N = 24), TFT (N = 24) or a wait-list condition (WLC) (N = 24) after a diagnostic procedure including the MINI PLUS that was performed before treatment or WLC. Following a 3 months waiting period, the WL patients were randomized to CBT (n = 12) or TFT (n = 12), and all patients were reassessed after treatment or waiting period and at 12 months follow-up. At first we compared the three groups CBT, TFT, and WL. After the post WL randomization, we compared CBT (N = 12 + 24 = 36) to TFT (N = 12 + 24 = 36), applying the pre-treatment scores as baseline for all patients. The primary outcome measure was a symptom score from the Anxiety Disorders Interview Scale that was performed by an interviewer blinded to the treatment condition. For statistical comparisons, we used the independent sample’s t-test, the Fisher’s exact test and the ANOVA and ANCOVA tests. Results: Both CBT and TFT showed better results than the WLC (p < 0.001) at post-treatment. Post-treatment and at the 12-month follow-up, there were not significant differences between CBT and TFT (p = 0.33 and p = 0.90, respectively). Conclusion: This paper reports the first study comparing TFT to CBT for any disorder. The study indicated that TFT may be an efficient treatment for patients with agoraphobia. Trial Registration: https://clinicaltrials.gov/, identifier NCT00932919.en_US
dc.languageEN
dc.language.isoenen_US
dc.publisherFrontiers Research Foundation
dc.relation.ispartofIrgens, Audun Campbell (2018) Thought field therapy for patients with anxiety disorders. Doctoral thesis. http://hdl.handle.net/10852/66248
dc.relation.urihttp://hdl.handle.net/10852/66248
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleThought field therapy compared to cognitive behavioral therapy and wait-list for agoraphobia: A randomized, controlled study with a 12-month follow-upen_US
dc.typeJournal articleen_US
dc.creator.authorIrgens, Audun Campbell
dc.creator.authorHoffart, Asle
dc.creator.authorNysæter, Tor Erik
dc.creator.authorHaaland, Vegard Øksendal
dc.creator.authorBorge, Finn Magnus
dc.creator.authorPripp, Are Hugo
dc.creator.authorMartinsen, Egil Wilhelm
dc.creator.authorDammen, Toril
cristin.unitcode185,17,5,0
cristin.unitnamePsykologisk institutt
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.fulltextoriginal
cristin.qualitycode2
dc.identifier.cristin1481176
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Frontiers in Psychology&rft.volume=8&rft.spage=&rft.date=2017
dc.identifier.jtitleFrontiers in Psychology
dc.identifier.volume8
dc.identifier.pagecount14
dc.identifier.doihttp://dx.doi.org/10.3389/fpsyg.2017.01027
dc.identifier.urnURN:NBN:no-63645
dc.type.documentTidsskriftartikkelen_US
dc.type.peerreviewedPeer reviewed
dc.source.issn1664-1078
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/61016/4/fpsyg-08-01027.pdf
dc.type.versionPublishedVersion
cristin.articleid1027


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International